Table 3 Characteristics of individual patients with hypoglycemia
Sex/age | BMI (kg/m2) | DM duration (years) | Blood glucose level (mg/dL) | HbA1c (%) | HOMA-IR | Urinary CPR (μg/day) | Therapy | |
|---|---|---|---|---|---|---|---|---|
1 | M/72 | 23.8 | 1 | 64 | 6.4 | – | – | DPP4i |
2 | F/75 | 20.8 | 25 | 63 | 6.4 | 0.7 | 12.9 | Insulin mix50 |
3 | M/58 | 21.2 | 38 | 56 | 6.8 | – | – | Insulin, DPP4i |
4 | F/73 | 25.2 | 25 | 42 | 6.9 | – | 11.1 | Insulin mix30 |
5 | F/17 | 21.0 | 5 | 65 | 7.3 | 0.8 | 29.3 | Biguanides |
6 | F/57 | 30.9 | 5 | 60 | 7.4 | 1.1 | 75.6 | DPP4i |
7 | M/74 | 23.7 | 17 | 64 | 7.6 | – | 1.1 | Insulin mix25 |
8 | M/70 | 27.4 | 32 | 62 | 7.6 | 0.7 | 19.4 | Sulfonylureas, DPP4i, biguanides, Thiazolidinedione |
9 | F/79 | 15.9 | 13 | 67 | 8 | – | 11.6 | Insulin, αGI |
10 | F/67 | 22.0 | 9 | 65 | 8.1 | 5.9 | 41.7 | DPP4i, glinide, αGI |
11 | M/34 | 27.3 | 4 | 57 | 8.4 | 0.9 | 14.4 | DPP4i |
12 | M/70 | 34.0 | 11 | 65 | 8.5 | 9.6 | 104.8 | DPP4i |
13 | F/70 | 22.4 | 25 | 47 | 8.5 | 0.9 | 32 | Sulfonylureas, DPP4i, Thiazolidinedione |
14 | M/36 | 38.4 | 2 | 59 | 8.6 | 9.0 | 182.1 | DPP4i |
15 | F/65 | 20.6 | 30 | 60 | 8.7 | 1.8 | 24.9 | Sulfonylureas, DPP4i, biguanides |